Marc Turner

Marc Turner is Director of the Scottish National Blood Transfusion Service and Professor of Cellular Therapy at the University of Edinburgh. His research interests include the translation ATMPs to clinical practice. He is currently Chair of the Global Alliance on iPSC Therapies, a Commissioner on the Commission on Human Medicines and is a member of its COVID-19 Vaccines Benefit-Risk Expert Working Group and Chair of its Clinical Trials, Biologicals and Vaccines Expert Advisory Group.